2023 AHA／ACC／ACCP／ASPC／NLA／PCNA慢性冠状动脉疾病患者管理指南.pdfVIP

Circulation CLINICAL PRACTICE GUIDELINE 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines Developed in Collaboration With and Endorsed by the American College of Clinical Pharmacy, American Society for Preventive Cardiology, National Lipid Association, and Preventive Cardiovascular Nurses Association Endorsed by the Society for Cardiovascular Angiography and Interventions Writing Committee Members* Salim S. Virani, MD, PhD, FACC, FAHA, FASPC, Chair†; L. Kristin Newby, MD, MHS, FACC, FAHA, Vice Chair†; Suzanne V. Arnold, MD, MHA, FAHA; Vera Bittner, MD, MSPH, FACC, FAHA, MNLA‡; LaPrincess C. Brewer, MD, MPH, FACC, FASPC; D Susan Halli Demeter, DNP, FNLA, FPCNA§; Dave L. Dixon, PharmD, FAHA, FACC, FCCP, FNLA||; William F. Fearon, MD, FAHA, FACC; o w n Beverly Hess, MSW¶; Heather M. Johnson, MD, MS, FAHA, FACC, FASPC#**; Dhruv S. Kazi, MD, MSc, MS, FAHA, FACC; l o a d Dhaval Kolte, MD, PhD, FACC††; Dharam J. Kumbhani, MD, SM, FAHA, FACC; Jim LoFaso¶; Dhruv Mahtta, DO, MBA; e d Daniel B. Mark, MD, MPH, FACC, FAHA||; Margo Minissian, PhD, ACNP, FAHA; Ann Marie Navar, MD, PhD, FAHA, FACC, FASPC; f r o m Amit R. Patel, MD, FACC; Mariann R. Piano, RN, PhD, FAHA||; Fatima Rodriguez, MD, MPH, FACC, FAHA; Amy W. Talbot, MPH†; h t Viviany R. Taqueti, MD, MPH, FACC, FAHA; Randal J. Thomas, MD, MS, FACC, FAHA; Sean van Diepen, MD, MSc, FAHA; t p : / / Barbara Wiggins, PharmD, MBA, FACC, FNLA, FCCP‡‡; Marlene S. Williams, MD, FACC§§ a h a j o u r AIM: The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary n a l s D